Authors:
Mikola, MK
Rahman, NA
Paukku, TH
Ahtiainen, PM
Vaskivuo, TE
Tapanainen, JS
Poutanen, M
Huhtaniemi, IT
Citation: Mk. Mikola et al., Gonadal tumors of mice double transgenic for inhibin-alpha promoter-drivensimian virus 40 T-antigen and herpes simplex virus thymidine kinase are sensitive to ganciclovir treatment, J ENDOCR, 170(1), 2001, pp. 79-90
Authors:
Vaskivuo, TE
Anttonen, M
Herva, R
Billig, H
Dorland, M
te Velde, ER
Stenback, F
Heikinheimo, M
Tapanainen, JS
Citation: Te. Vaskivuo et al., Survival of human ovarian follicles from fetal to adult life: Apoptosis, apoptosis-related proteins, and transcription factor GATA-4, J CLIN END, 86(7), 2001, pp. 3421-3429
Authors:
Koivunen, RM
Juutinen, J
Vauhkonen, I
Morin-Papunen, LC
Ruokonen, A
Tapanainen, JS
Citation: Rm. Koivunen et al., Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes, J CLIN END, 86(6), 2001, pp. 2591-2599
Authors:
Isojarvi, JIT
Tauboll, E
Tapanainen, JS
Pakarinen, AJ
Laatikainen, TJ
Knip, M
Myllyla, VV
Citation: Jit. Isojarvi et al., On the association between valproate and polycystic ovary syndrome: A response and an alternative view, EPILEPSIA, 42(3), 2001, pp. 305-310
Authors:
Isojarvi, JIT
Tauboll, E
Pakarinen, AK
van Parys, J
Rattya, J
Harbo, HF
Dale, PO
Fauser, BCJM
Gjerstad, L
Koivunen, R
Knip, M
Tapanainen, JS
Citation: Jit. Isojarvi et al., Altered ovarian function and cardiovascular risk factors in valproate-treated women, AM J MED, 111(4), 2001, pp. 290-296
Authors:
Morin-Papunen, LC
Vauhkonen, I
Koivunen, RM
Ruokonen, A
Tapanainen, JS
Citation: Lc. Morin-papunen et al., Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome, HUM REPR, 15(6), 2000, pp. 1266-1274
Authors:
Juutinen, J
Hartikainen, AL
Bloigu, R
Tapanainen, JS
Citation: J. Juutinen et al., A retrospective study on 435 women with gestational diabetes - Fasting plasma glucose is not sensitive enough for screening but predicts a need for insulin treatment, DIABET CARE, 23(12), 2000, pp. 1858-1859
Authors:
Morin-Papunen, LC
Vauhkonen, I
Koivunen, RM
Ruokonen, A
Martikainen, HK
Tapanainen, JS
Citation: Lc. Morin-papunen et al., Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: A randomizedstudy, J CLIN END, 85(9), 2000, pp. 3161-3168
Authors:
Ketola, I
Pentikainen, V
Vaskivuo, T
Ilvesmaki, V
Herva, R
Dunkel, L
Tapanainen, JS
Toppari, J
Heikinheimo, M
Citation: I. Ketola et al., Expression of transcription factor GATA-4 during human testicular development and disease, J CLIN END, 85(10), 2000, pp. 3925-3931
Citation: Jit. Isojarvi et Js. Tapanainen, Valproate, hyperandrogenism, and polycystic ovaries - A report of 3 cases, ARCH NEUROL, 57(7), 2000, pp. 1064-1068
Authors:
Vainionpaa, LK
Rattya, J
Knip, M
Tapanainen, JS
Pakarinen, AJ
Lanning, P
Tekay, A
Myllyla, VV
Isojarvi, JIT
Citation: Lk. Vainionpaa et al., Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy, ANN NEUROL, 45(4), 1999, pp. 444-450
Authors:
Tapanainen, JS
Koivunen, R
Fauser, BCJM
Taylor, AE
Clayton, RN
Rajkowa, M
White, D
Franks, S
Anttila, L
Pettersson, KSI
Huhtaniemi, IT
Citation: Js. Tapanainen et al., A new contributing factor to polycystic ovary syndrome: The genetic variant of luteinizing hormones, J CLIN END, 84(5), 1999, pp. 1711-1715
Authors:
Ketola, I
Rahman, N
Toppari, J
Bielinska, M
Porter-Tinge, SB
Tapanainen, JS
Huhtaniemi, IT
Wilson, DB
Heikinheimo, M
Citation: I. Ketola et al., Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis, ENDOCRINOL, 140(3), 1999, pp. 1470-1480